Overview
Transcatheter tricuspid valve replacement (TTVR) is associated with a high risk of third-degree atrioventricular block (AVB). However, the optimal pacemaker management following TTVR remains unclear. This study aims to identify an optimal therapeutic approach for pacemaker implantation in patients undergoing TTVR.
Eligibility
Inclusion Criteria:
- Transcatheter Tricuspid Valve Replacement
Exclusion Criteria:
- no defined exclusion criteria